Eko Foundation Analysis Software with Transformers (EFAST) vs iPredict Eye Screening

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Eko Foundation Analysis Software with Transformers (EFAST)

by Eko Health

iPredict Eye Screening

by iHealthScreen

AI Verdict

EFAST is designed for real-time cardiac auscultation analysis, aiding in the detection of structural murmurs and atrial fibrillation. In contrast, iPredict Eye Screening leverages AI for the early detection of retinal diseases such as diabetic retinopathy, age-related macular degeneration, and glaucoma, and offers risk prediction for systemic conditions. While both are FDA-cleared, cloud-based AI screening tools applicable in primary care, they address fundamentally different organ systems and diagnostic modalities.

Choose Eko Foundation Analysis Software with Transformers (EFAST) if…

Choose EFAST if your primary need is real-time, AI-assisted cardiac assessment during routine physical examinations. This tool is ideal for clinicians seeking immediate insights into structural murmurs associated with heart disease and the presence of atrial fibrillation, directly integrated with auscultation. It streamlines the detection of critical cardiac conditions, enhancing diagnostic confidence in seconds.

View Eko Foundation Analysis Software with Transformers (EFAST) →

Choose iPredict Eye Screening if…

Choose iPredict Eye Screening if you require an efficient, AI-powered solution for comprehensive retinal disease screening and systemic health risk prediction. This tool is best suited for identifying age-related macular degeneration, diabetic retinopathy, and glaucoma, while also offering valuable insights into stroke and heart attack risk, all through a quick, non-invasive eye scan. It's particularly useful in primary care or telemedicine for broad patient screening.

View iPredict Eye Screening →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Eko Foundation Analysis Software with Transformers (EFAST)	iPredict Eye Screening
Pricing	Subscription-based, contact for details	Contact for pricing
Deployment	Cloud-based Software as a Medical Device (SaMD)	Cloud-based (Software as a Medical Device), accessible in primary care settings, clinics, hospitals, and online for telemedicine and prediction apps.
BAA Available	Yes AI-estimated	Unknown
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Eko Foundation Analysis Software with Transformers (EFAST)

EFAST offers real-time AI analysis during auscultation and guided exams, seamlessly integrating with Eko digital stethoscopes. This provides a highly embedded and assistive user experience within an existing, hands-on clinical procedure, making it a natural extension of the workflow.

Clinical Value

iPredict Eye Screening

iPredict Eye Screening provides a broader clinical scope by screening for three critical ophthalmic conditions (AMD, DR, Glaucoma) and offering risk prediction for systemic diseases like stroke and heart attack. This comprehensive approach adds significant value beyond just eye health, addressing multiple patient needs.

Pricing & Value

iPredict Eye Screening

iPredict Eye Screening offers a more transparent pricing model with an estimated per-patient cost ($10-$20), directly linked to potential Medicare/commercial payor reimbursement. This allows for clearer budgeting and a more straightforward calculation of return on investment compared to EFAST's subscription-based model with less immediate transparency on software-only costs.

Enterprise Readiness

Eko Foundation Analysis Software with Transformers (EFAST)

EFAST explicitly states it has a Business Associate Agreement (BAA), which is a critical legal and compliance requirement for healthcare enterprises handling Protected Health Information (PHI). While both are FDA-cleared, HIPAA compliant, and cloud-based with EMR/EHR integration, Tool B does not explicitly mention BAA availability, which is a significant gap for enterprise adoption.

Innovation

Eko Foundation Analysis Software with Transformers (EFAST)

EFAST's explicit mention of 'Transformers' in its name suggests the use of a cutting-edge AI architecture for cardiac sound analysis. Its real-time AI analysis integrated directly into the auscultation workflow represents a significant innovation in how AI is applied to enhance immediate clinical decision-making during a physical exam.

Support & Docs

Eko Foundation Analysis Software with Transformers (EFAST)

Eko Health, as a more established company with a broader product line including hardware, demonstrates a more visible and comprehensive support infrastructure. Their website offers a dedicated Help Center, FAQs, live Q&A sessions, and various contact options for support, indicating a robust system for user assistance and documentation.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Eko Foundation Analysis Software with Transformers (EFAST)	iPredict Eye Screening
Product Name	Eko Foundation Analysis Software with Transformers (EFAST)	iPredict Eye Screening
Company	Eko Health	iHealthScreen
Primary Medical Specialties	Cardiology, Family Medicine, Internal Medicine	Family Medicine, Internal Medicine, Ophthalmology
Key AI Detections/Screenings	AI-powered structural murmur detection, AI-powered atrial fibrillation (AFib) detection	AI-Based Screening for Diabetic Retinopathy (DR), Age-related Macular Degeneration (AMD), and Glaucoma; Online Health Risk Prediction System for Diabetic, Stroke, and Heart Attack patients
EMR/EHR Integration	EMR integration for streamlined documentation	Integrates with EHR

Videos

Demos, reviews, and walkthroughs featuring Eko Foundation Analysis Software with Transformers (EFAST) and iPredict Eye Screening.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools integrate into a typical patient visit, and what kind of real-time or rapid insights can a physician expect?

EFAST by Eko Health provides real-time AI analysis during auscultation, offering immediate cardiac insights into structural murmurs and atrial fibrillation. iPredict Eye Screening delivers rapid results, completing a test in less than 5 minutes with a fully automated report generated in under 60 seconds for retinal disease and systemic risk prediction.

What specific clinical conditions does each tool help identify, and how do their diagnostic scopes differ for a general practitioner?

EFAST focuses on critical cardiac conditions, assisting in the identification of structural murmurs associated with heart disease and detecting atrial fibrillation. iPredict Eye Screening offers a broader scope, screening for Diabetic Retinopathy (DR), Age-related Macular Degeneration (AMD), Glaucoma, and providing risk prediction for systemic diseases like stroke and heart attack.

What are the reported accuracy (sensitivity and specificity) metrics for the primary conditions each tool is designed to detect?

EFAST boasts high accuracy for cardiac conditions, with 93% sensitivity and 91% specificity for structural murmurs, and 95% sensitivity and 94% specificity for AFib. iPredict Eye Screening reports approximately 95% average accuracy, with AMD detection specifically at 86.86% sensitivity and 94.13% specificity, and stroke prediction at 82.73% sensitivity and 87.35% specificity.

How deeply do these tools integrate with existing Electronic Health Record (EHR) systems to streamline documentation and data management?

EFAST offers EMR integration for streamlined documentation of cardiac exam findings and AI analysis results directly into patient records. iPredict Eye Screening also provides Electronic Health Record (EHR) Solutions to integrate screening data and risk predictions efficiently.

What is the expected learning curve for clinical staff, and how user-friendly are these systems for routine operation?

EFAST integrates seamlessly with Eko digital stethoscopes, leveraging familiar auscultation techniques, which suggests a relatively low learning curve for physicians. iPredict Eye Screening is described as easy to operate, non-invasive, and features an advanced touchscreen interface, facilitating quick adoption by clinical staff.

What considerations are there for deploying and managing these tools across multiple clinical sites or practices?

Both tools are cloud-based Software as a Medical Device (SaMD), which inherently supports multi-site deployment and remote accessibility. This architecture allows for centralized management and consistent access across various clinic locations, making them suitable for multi-site rollouts.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform

AISAP Cardio vs Rapid Enterprise Platform

AngioWaveNet vs Rapid Enterprise Platform

CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring Eko Foundation Analysis Software with Transformers (EFAST) or iPredict Eye Screening

Backers

Who funded each tool's parent company.